E. Sánchez, A. Mejía-toiber, J. Massieu, L. Southwell, A. Ko et al., Excitotoxic neuronal death and the pathogenesis of Huntington's disease Intrabody gene therapy ameliorates motor, cognitive , and neuropathological symptoms in multiple mouse models of Huntington's disease 4 Bachoud-Lévi A-C. Neural grafts in Huntington's disease: Viability after 10 years Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration, Pavese N et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease, pp.971-983265, 1993.

K. Takahashi, S. Yamanaka, S. Yamanaka, H. Blau, M. Wernig et al., In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Generation of germline-competent induced pluripotent stem cells The role of induced pluripotent stem cells in regenerative medicine: Neurodegenerative diseases Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum Cell Transplant 2013 [Epub ahead of print]. 13 Túnez I, Tasset I, Pérez-De La Cruz V et al. 3- Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: Past, present and future Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: Morphological and behavioral outcomes Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid 17 Beal MF. Huntington's disease, energy, and excitotoxicity Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease, Thinard R et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation The Rat Brain in Stereotaxic Coordinates Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator, pp.663-676704, 1994.

R. Armstrong, C. Watts, and C. Svendsen, Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum Striatal transplantation in a transgenic mouse model of Huntington's disease, Anat Rec Cell Transplant J Neurosci Exp Neurol, vol.231926154, pp.482-49755, 1991.

J. Ryu, J. Kim, and S. Cho, Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease Human embryonic stem cell-derived neural precursor transplants attenuate apomorphineinduced rotational behavior in rats with unilateral quinolinic acid lesions Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model, Human neural stem cell transplants improve P et al. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: Optical neuroimage tracking of brain-grafted cells, pp.211-219, 2004.

T. Roberts, J. Price, and S. Williams, Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease, J et al. Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: Use of gangliosides, substituted pyrimidines, and mesenchymal stem cells, pp.1187-1199, 1998.

L. 38-lescaudron, D. Unni, G. Dunbar, L. Ma, B. Hu et al., Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: Behavioral and morphological outcomes Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells, Transplantation of induced pluripotent stem cells without C-Myc attenuates retinal ischemia and reperfusion injury in rats, pp.63-79945, 2003.

S. Stemcellstm, com for supporting information available online

. Fink and L. Crane,